Search research articles
Contact Us
Filters
Showing results (41-50 of 442) with videos related to
Page
of 45
Sort By:
Oncotarget
|
July 16, 2016
An appraisal of drug development timelines in the Era of precision oncology
Denis Leonardo Jardim, Maria Schwaederle, David S Hong, et al.
Targeted Oncology
|
February 13, 2013
Bevacizumab-based treatment in colorectal cancer with a NRAS Q61K mutation
Filip Janku, Jennifer J Wheler, David S Hong, et al.
Cancer Discovery
|
June 4, 2017
Targeting <i>BRAF</i>-Mutant Colorectal Cancer: Progress in Combination Strategies
Raghav Sundar, David S Hong, Scott Kopetz, et al.
Nature Reviews. Clinical Oncology
|
May 19, 2011
Autophagy as a target for anticancer therapy
Filip Janku, David J McConkey, David S Hong, et al.
Asian Journal of Neurosurgery
|
October 18, 2021
Pediatric Central Nervous System Cancers in the Democratic People's Republic of Korea
Sunwoo Park, Sandra Moon, David S Hong, et al.
JCEM Case Reports
|
June 5, 2026
Tirzepatide for weight and behavior management in a patient with Smith-Magenis syndrome
X Charlene Liao, Tao Huang, David S Hong, et al.
Journal of Immunotherapy and Precision Oncology
|
January 15, 2025
Durable Remission After Targeted Therapy in <i>BRAF V600E-</i>Mutant Metastatic Colorectal Cancer: Case Report
Daniel A Fox, Deepak Bhamidipati, Scott Kopetz, et al.
Cerebral Cortex (New York, N.Y. : 1991)
|
March 29, 2011
Reduced functional connectivity during working memory in Turner syndrome
Signe Bray, Bria Dunkin, David S Hong, et al.
Human Brain Mapping
|
June 20, 2012
Aberrant functional network recruitment of posterior parietal cortex in Turner syndrome
Signe Bray, Fumiko Hoeft, David S Hong, et al.
Journal of Immunotherapy and Precision Oncology
|
March 11, 2025
Treatment of c-MET Antibody-Drug Conjugate Asymptomatic Pneumonitis with a Novel Steroid Regimen in Non-Small Cell Lung Cancer: A Case Report
Daniel A Fox, Christine Tran, Vincent Blot, et al.
Page
of 45
Search research articles
Search
Showing results (41-50 of 442) with videos related to
Sort By:
Page
of 45
Oncotarget
|
July 16, 2016
An appraisal of drug development timelines in the Era of precision oncology
Denis Leonardo Jardim, Maria Schwaederle, David S Hong, et al.
Targeted Oncology
|
February 13, 2013
Bevacizumab-based treatment in colorectal cancer with a NRAS Q61K mutation
Filip Janku, Jennifer J Wheler, David S Hong, et al.
Cancer Discovery
|
June 4, 2017
Targeting <i>BRAF</i>-Mutant Colorectal Cancer: Progress in Combination Strategies
Raghav Sundar, David S Hong, Scott Kopetz, et al.
Nature Reviews. Clinical Oncology
|
May 19, 2011
Autophagy as a target for anticancer therapy
Filip Janku, David J McConkey, David S Hong, et al.
Asian Journal of Neurosurgery
|
October 18, 2021
Pediatric Central Nervous System Cancers in the Democratic People's Republic of Korea
Sunwoo Park, Sandra Moon, David S Hong, et al.
JCEM Case Reports
|
June 5, 2026
Tirzepatide for weight and behavior management in a patient with Smith-Magenis syndrome
X Charlene Liao, Tao Huang, David S Hong, et al.
Journal of Immunotherapy and Precision Oncology
|
January 15, 2025
Durable Remission After Targeted Therapy in <i>BRAF V600E-</i>Mutant Metastatic Colorectal Cancer: Case Report
Daniel A Fox, Deepak Bhamidipati, Scott Kopetz, et al.
Cerebral Cortex (New York, N.Y. : 1991)
|
March 29, 2011
Reduced functional connectivity during working memory in Turner syndrome
Signe Bray, Bria Dunkin, David S Hong, et al.
Human Brain Mapping
|
June 20, 2012
Aberrant functional network recruitment of posterior parietal cortex in Turner syndrome
Signe Bray, Fumiko Hoeft, David S Hong, et al.
Journal of Immunotherapy and Precision Oncology
|
March 11, 2025
Treatment of c-MET Antibody-Drug Conjugate Asymptomatic Pneumonitis with a Novel Steroid Regimen in Non-Small Cell Lung Cancer: A Case Report
Daniel A Fox, Christine Tran, Vincent Blot, et al.
Page
of 45